{"log_id": 8723210418849836830, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.001953, "average": 0.97363, "min": 0.781672}, "location": {"width": 1102, "top": 208, "height": 38, "left": 237}, "words": "利奈唑胺上市后的临床应用中,有骨髓抑制报道(包括贫血、白细胞减少、血细胞减少和"}, {"probability": {"variance": 0.014073, "average": 0.940672, "min": 0.54438}, "location": {"width": 1104, "top": 248, "height": 35, "left": 234}, "words": "血小板减少〕见警告)。曾有周围神经病和视神经病变有时进展至失明的报道。应用利奈唑"}, {"probability": {"variance": 0.01033, "average": 0.952039, "min": 0.576755}, "location": {"width": 1104, "top": 286, "height": 40, "left": 234}, "words": "胺过程中,有乳酸性酸中毒投道见【注意事项】一般注意事项)虽然上述报道主要出"}, {"probability": {"variance": 0.026955, "average": 0.903372, "min": 0.359033}, "location": {"width": 1100, "top": 331, "height": 33, "left": 239}, "words": "现在应利奈唑按超过推荐的最长应用时间(2天)的患着,但在用药时间较短的患者"}, {"probability": {"variance": 0.01947, "average": 0.908493, "min": 0.433323}, "location": {"width": 1102, "top": 373, "height": 33, "left": 239}, "words": "中也有报道。利奈按合用5-羟色按关药物,包括抗扣郁药物如:过择性5-羟色胺摄取"}, {"probability": {"variance": 0.035249, "average": 0.884109, "min": 0.35861}, "location": {"width": 1091, "top": 411, "height": 38, "left": 237}, "words": "抑制剂55s的志者,有一色股综合征的投告(【注意事项】,一般注意事项)"}, {"probability": {"variance": 0.010223, "average": 0.962656, "min": 0.442986}, "location": {"width": 1104, "top": 454, "height": 35, "left": 234}, "words": "在利奈唑胺应用的过程中有惊的报道(见【注意事项】,一般注意事项).过敏性反、血"}, {"probability": {"variance": 0.025927, "average": 0.935169, "min": 0.480561}, "location": {"width": 266, "top": 501, "height": 31, "left": 237}, "words": "管性水肿、为Ste"}, {"probability": {"variance": 0.016202, "average": 0.934162, "min": 0.527585}, "location": {"width": 677, "top": 496, "height": 33, "left": 662}, "words": "综合征的皮肤水疱也有报道。曾有使用利奈挫胺后出现"}, {"probability": {"variance": 0.013474, "average": 0.937679, "min": 0.49336}, "location": {"width": 1102, "top": 536, "height": 35, "left": 237}, "words": "牙齿和舌褪色的报道。在已知结朱的病例中,牙齿褪色可以通过专业牙科清洁(手工院"}, {"probability": {"variance": 0.027879, "average": 0.906066, "min": 0.365366}, "location": {"width": 1082, "top": 579, "height": 35, "left": 239}, "words": "垢)清除,有低血糖包括症状发作的道(见警告)。这些小良事件可能由重性"}, {"probability": {"variance": 0.023413, "average": 0.898116, "min": 0.35766}, "location": {"width": 1102, "top": 617, "height": 38, "left": 239}, "words": "报告的频度、与利奈按可能的相关生,或同时什有以上多种因素而被列出、于上述事件"}, {"probability": {"variance": 0.016249, "average": 0.935828, "min": 0.528192}, "location": {"width": 1109, "top": 659, "height": 38, "left": 234}, "words": "为白发性报告:无法知烧其束源于多人样本的患者人群,故不能对其发生率进行估计,也不"}, {"probability": {"variance": 0.027359, "average": 0.876108, "min": 0.542104}, "location": {"width": 420, "top": 704, "height": 33, "left": 239}, "words": "能确地判定其与用药的囚果关系"}, {"probability": {"variance": 0, "average": 0.99914, "min": 0.99842}, "location": {"width": 105, "top": 787, "height": 35, "left": 246}, "words": "【禁忌】"}, {"probability": {"variance": 0.03602, "average": 0.884558, "min": 0.390426}, "location": {"width": 668, "top": 825, "height": 35, "left": 297}, "words": "本品禁用于已知对奈或本品其他成分过敏的思者"}, {"probability": {"variance": 0.000333, "average": 0.985195, "min": 0.955838}, "location": {"width": 225, "top": 910, "height": 33, "left": 241}, "words": "单胺氧化酶抑制剂"}, {"probability": {"variance": 0.025183, "average": 0.911628, "min": 0.401672}, "location": {"width": 1051, "top": 946, "height": 38, "left": 295}, "words": "正在使用任何能抑制草胺氧化酶A或B的药物至如:苯乙肼、异卡波>的患者,或两"}, {"probability": {"variance": 0.0168, "average": 0.935249, "min": 0.590971}, "location": {"width": 612, "top": 990, "height": 33, "left": 243}, "words": "周内曾经使用过这类药物的患名不应使用利奈唑胺"}, {"probability": {"variance": 0.000784, "average": 0.987903, "min": 0.896186}, "location": {"width": 369, "top": 1073, "height": 35, "left": 241}, "words": "引起血压升高的潜在相互作"}, {"probability": {"variance": 0.012662, "average": 0.944572, "min": 0.505169}, "location": {"width": 1049, "top": 1109, "height": 35, "left": 299}, "words": "除卡能够对于者可能出现的血压升高进行监测,否则利奈唑按不应用于高血压控制"}, {"probability": {"variance": 0.042624, "average": 0.793626, "min": 0.418813}, "location": {"width": 1104, "top": 1147, "height": 44, "left": 243}, "words": "的患考、铬细胞瘤、甲状腺机让的者和/或使用以下午何药物的患:直接线问按"}, {"probability": {"variance": 0.022719, "average": 0.902983, "min": 0.46124}, "location": {"width": 1104, "top": 1187, "height": 44, "left": 243}, "words": "拟交感经药物如伪黄诚),血管加药物(如:肾上腺素,去甲上腺素)。多巴胺类"}, {"probability": {"variance": 0.024543, "average": 0.931961, "min": 0.405393}, "location": {"width": 849, "top": 1230, "height": 42, "left": 243}, "words": "药物〔如:多巴胺、多巴纷丁)见【注意事项】、【药物互作用】"}, {"probability": {"variance": 0.001409, "average": 0.981017, "min": 0.859288}, "location": {"width": 429, "top": 1317, "height": 35, "left": 246}, "words": "与5-羟色胺类药物潜在的相互作用"}, {"probability": {"variance": 0.030876, "average": 0.874059, "min": 0.422306}, "location": {"width": 1046, "top": 1351, "height": 46, "left": 299}, "words": "除卡密切观察患者行羟色按综合征的体征和/症状,否则利杂唑胺不应用类综合"}, {"probability": {"variance": 0.024589, "average": 0.907946, "min": 0.477829}, "location": {"width": 1017, "top": 1393, "height": 42, "left": 248}, "words": "征的者和或使用任何以下药物的患者:5径色胺再摄取排制剂,三环类抑郁药"}, {"probability": {"variance": 0.017545, "average": 0.913968, "min": 0.589787}, "location": {"width": 1080, "top": 1424, "height": 53, "left": 246}, "words": "色按5T1受体激动剂《曲普坦类药物)、哌啶城丁螺环酮(见【注意事项】般注"}, {"probability": {"variance": 0.000611, "average": 0.988842, "min": 0.911231}, "location": {"width": 279, "top": 1482, "height": 33, "left": 250}, "words": "项和【药物相互作用】)"}, {"probability": {"variance": 2.6e-05, "average": 0.996227, "min": 0.985423}, "location": {"width": 154, "top": 1565, "height": 33, "left": 257}, "words": "【注意事项】"}, {"probability": {"variance": 0.024899, "average": 0.913716, "min": 0.416975}, "location": {"width": 1013, "top": 1592, "height": 53, "left": 308}, "words": "为减少村药的产生,并保本品和其他抗菌药物的疗效,利唑该仅用干"}, {"probability": {"variance": 0.036979, "average": 0.829463, "min": 0.367593}, "location": {"width": 666, "top": 1644, "height": 38, "left": 252}, "words": "或顶已经实成者高度怀疑细菌引起的感染性疾病"}, {"probability": {"variance": 8e-06, "average": 0.986289, "min": 0.983528}, "location": {"width": 60, "top": 1690, "height": 33, "left": 250}, "words": "警告"}, {"probability": {"variance": 0.002979, "average": 0.979062, "min": 0.713344}, "location": {"width": 1051, "top": 1720, "height": 46, "left": 306}, "words": "在应用利奈唑胺的患者中有出现骨髓抑制的报道(包括贫血、白细胞减少、全血细胞"}, {"probability": {"variance": 0.006071, "average": 0.971775, "min": 0.569968}, "location": {"width": 1100, "top": 1760, "height": 49, "left": 254}, "words": "减少和血小板减少)。在已知转归的病例中,用利奈唑胺后血象指标可以上升并回复到治"}, {"probability": {"variance": 0.008478, "average": 0.975701, "min": 0.453005}, "location": {"width": 1107, "top": 1800, "height": 49, "left": 252}, "words": "疗前的水平。对应用利奈唑胺的患者应每周进行全血细胞计数的检查,尤其是那些用药超"}, {"probability": {"variance": 0.009938, "average": 0.971058, "min": 0.481795}, "location": {"width": 1109, "top": 1840, "height": 51, "left": 250}, "words": "过两周,或用药前已有骨髓抑制,或合并应用能导致发生骨髓抑制的其他药物,或患慢性"}, {"probability": {"variance": 0.003227, "average": 0.97354, "min": 0.759349}, "location": {"width": 1102, "top": 1883, "height": 49, "left": 254}, "words": "感染既往或目前合并接受其他抗生素治疗的患者:对发生骨髓抑制或抑制发生化的"}, {"probability": {"variance": 0.000824, "average": 0.987802, "min": 0.889218}, "location": {"width": 364, "top": 1932, "height": 35, "left": 254}, "words": "患者应考虑停用利奈唑胺治疗"}, {"probability": {"variance": 0.023011, "average": 0.90517, "min": 0.37276}, "location": {"width": 1037, "top": 1968, "height": 44, "left": 308}, "words": "在成半和术成年的狗和人鼠中,普观察到抑制、脏和肛的外血细胞生成减少"}, {"probability": {"variance": 0.042357, "average": 0.861922, "min": 0.392085}, "location": {"width": 181, "top": 2013, "height": 29, "left": 718}, "words": "第9。25页"}], "language": 3}